The codon 72 polymorphic variants of p53 in Italian rheumatoid arthritis patients

Clinical and Experimental Rheumatology

Volumn 25, Issue 3, 2007, Pages 416-421

  Macchioni, Pierluigi ^a   Nicoli, Davide ^a   Casali, Bruno ^a   Catanoso, Mariagrazia ^a   Farnetti, Enrico ^a   Boiardi, Luigi ^a   Salvarani, Carlo ^a  

^a S MARIA NUOVA HOSPITAL   (Italy)

Author keywords

Bone erosions; p53 polymorphism; Rheumatoid arthritis

Indexed keywords

ARGININE; PROLINE; PROTEIN P53;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; BONE EROSION; BONE RADIOGRAPHY; CODON; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENOTYPE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; ONSET AGE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN POLYMORPHISM; PROTEIN VARIANT; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SEQUENCE ANALYSIS; WILD TYPE;

EID: 34447622519     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. HARRIS ED Jr: Rheumatoid arthritis. Pathophysiology and implication for therapy. N Engl J Med 1990; 322: 1277-89.
2. LIU H, POPE RM: Apoptosis in Fheumatoid arthritis: friend or foe. Rheum Dis Clin North Am 2004; 30: 603-25.
3. BAIER A, MEINECKEL I, GAY S, PAP T: Apoptosis in rheumatoid arthritis. Curr Opin Rheumatol 2003; 15: 274-9.
4. NISHIOKA K, HASUNUMA T, KATO T, KOBATA T: Apoptosis in rheumatoid arthritis: A novel pathway in the regulation of the synovial tissue. Arthritis Rheum 1998; 41: 1-9.
5. FIRESTEIN GS, NGUYEN K, AUPPERLE KR, YEO M, BOYLE DL, ZVAIFLER NJ: Apoptosis in rheumatoid arthritis: P53 overexpression in rheumatoid arthritis synovium. Am J Pathol 1996; 149: 2143-51.
6. TAK PP, SMEETS TJ, BOYLE DL et al.: P53 overexpression in synovial tissue from patients with early and longstanding rheumatoid arthritis compared with patients with reactive arthritis and osteoarthritis. Arthritis Rheum 1999; 42: 948-53.
7. MAAS K, WESTFALL M, PIETENPOL J, OLSEN NJ, AUNE T: Reduced p53 in peripheral blood mononuclear cells from patients with rheumatoide arthritis is associated with loss of radiation-induced apoptosis. Arthritis Rheum 2005; 52: 1047-57.
8. SIMELYTE E, ROSENGREN S, BOYLE DL, CORR M, GREEN DR, FIRESTEIN GS: Regulation of arthritis by p53. Critical role of adaptive immunity. Arthritis Rheum 2005; 52: 1876-84.
9. KOBAYASHI T, OKAMOTO K, KOBATA T, HASUNUMA T, KATO T, HAMADA H, NISHIOKA K: Differential regulation of Fas-mediated apoptosis of rheumatoid synoviocytes by tumor necrosis factor alpha and basic fibroblast growth factor is associated with the expression of apoptosis-related molecules. Arthritis Rheum 2000; 43: 1106-14.
10. MATSUMOTO S, MULLER-LADNER U, GAY RE, NISHIOKA K, GAY S: Ultrastructural demonstration of apoptosis, Fas and Bcl-2 expression of rheumatoid synovial fibroblasts. J Rheumatol 1996; 23: 1345-52.
11. SIOUD M, MELLBYE O, FORRE O: Analysis of the NF-kappa B p65 subunit, Fas antigen, Fas ligand and Bcl-2-related proteins in the synovium of RA and polyarticular JRA. Clin Exp Rheumatol 1998; 16: 125-34.
12. SUGIYAMA M, TSUKAZAKI T, YONEKURA A, MATSUZAKI S, YAMASHITA S, IWASAKI K: Localisation of apoptosis and expression of apoptosis-related proteins in the synovium of patients with rheumatoid arthritis. Ann Rheum Dis 1996; 55: 442-9.
13. KUROWSKA M, RUDNICKA W, KONTNY E et al.: Fibroblast-like synoviocytes from rheumatoid arthritis patients express functional IL-15 receptor complex: Endogenous IL-15 in autocrine fashion enhances cell proliferation and expression of Bcl-x(L) and Bcl-2. J Immunol 2002; 169: 1760-7.
14. PERLMAN H, PAGLIARI LJ, LIU H, KOCH AE, HAINES GK 3rd, POPE RM: Rheumatoid arthritis synovial macrophages express the Fas-associated death domain-like interleukin-1beta-converting enzyme-inhibitory protein and are refractory to Fas-mediated apoptosis. Arthritis Rheum 2001; 44: 21-30.
15. YAO Q, WANG S, GLORIOSO JC et al.: Gene transfer of p53 to arthritic joints stimulates synovial apoptosis and inhibits inflammation. Mol Ther 2001; 3: 901-10.
16. MARTIN DA, ELKON KB: Mechanisms of apoptosis. Rheum Dis Clin North Am 2004; 30: 441-54.
17. DVOUSDEN KH: P53: death star. Cell 2000; 103: 691-4.
18. EVAN G, LITTLEWOOD T: A matter of life and cell death. Science 1998; 281: 1317-22.
19. MATLASHEWSKI GJ, TUCK S, PIM D, LAMB P, SCHNEIDER J, CRAWFORD LV: Primary structure polymorphism at amino acid residue 72 of human p53. Mol Cell Biol 1987; 7: 961-3.
20. THOMAS M, KALITA A, LABRECQUE S, PIM D, BANKS L, MATLASHEWSKI G: Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol 1999; 19: 1092-100.
21. DUMONT P, LEU JI, DELLA PIETRA AC 3RD, GEORGE DL, MURPHY M: The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 2003; 33: 357-65.
22. ARNETT FC, EDWORTHY SM, BLOCH DA et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
23. MACCHIONI P, BOIARDI L, CASALI B, NICOLI D, FARNETTI E, SALVARANI C: Intercellular adhesion molecule 1 (ICAM-1) gene polymorphisms in Italian patients with rheumatoid arthritis. Clin Exp Rheumatol 2000; 18: 553-8.
24. Van der HEIJDE DMFM: How to read radiographs according to the Sharp/van der Heijde method. J Rheumatol 1999; 26: 743-5.
25. LARGEY JS, MELTZER SJ, YIN J, NORRIS K, SAUK JJ, ARCHIBALD DW: Loss of heterozygosity of p53 in oral cancers demonstrated by the polymerase chain reaction. Cancer 1993; 71: 1933-7.
26. LEE YH, KIM YR, JI JD, SOHN J, SONG GG: P53 codon 72 polymorphism and rheumatoid arthritis. J Rheumatol 2001; 28: 2392-4.
27. TAUBERT H, THAMM B, MEYE A et al.: The p53 status in juvenile chronic arthritis and rheumatoid arthritis. Clin Exp Immunol 2000; 122: 264-9.
28. MARGULIES L, SEHGAL PB: Modulation of the human interleukin-6 promoter (IL-6) and transcription factor C/EBP beta (NF-IL6) activity by p53 species. J Biol Chem 1993; 268: 15096-100.
29. YAMANISHI Y, BOYLE DL, ROSENGREN S, GREEN DR, ZVAIFLER NJ, FIRESTEIN GS: Regional analysis of p53 mutations in rheumatoid arthritis synovium. Proc Natl Acad Sci USA 2002; 99: 10025-30.
30. GENESTIER L, PAILLOT R, FOURNEL S, FERRARO C, MIOSSEC P, REVILLARD JP: Immunosuppressive properties of methotrexate: Apoptosis and clonal deletion of activated peripheral T cells. J Clin Invest 1998; 102: 322-8.
31. NAKAZAWA F, MATSUNO H, YUDOH K, KATAYAMA R, SAWAI T, UZUKI M, KIMURA T: Methotrexate inhibits rheumatoid synovitis by inducing apoptosis. J Rheumatol 2001; 28: 1800-8.
32. RODENBURG RJ, GANGA A, VAN LENT PL, van de PUTTE LB, van VENROOij WJ: The antiinflammatory drug sulfasalazine inhibits tumor necrosis factor alpha expression in macrophages by inducing apoptosis. Arthritis Rheum 2000; 43: 1941-50.
33. LIPTAY S, FULDA S, SCHANBACHER M et al.: Molecular mechanisms of sulfasalazine-induced T-cell apoptosis. Br J Pharmacol 2002; 137: 608-20.
34. CATRINA AI, TROLLMO C, af KLINT E et al.: Evidence that anti-tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints: Extended report. Arthritis Rheum 2005; 52: 61-72.
35. ALAS S, BONAVIDA B: Rituximab inactivates signal transducer and activation of transcription 3 (STAT3) activity in B-non-Hodgkin's lymphoma through inhibition of the interleukin 10 autocrine/paracrine loop and results in down-regulation of Bcl-2 and sensitization to cytotoxic drugs. Cancer Res 2001; 61: 5137-44.
36. SZODORAY P, ALEX P, DANDAPANI V et al.: Apoptotic effect of rituximab on peripheral blood B cells in rheumatoid arthritis. Scand J Immunol 2004; 60: 209-18.